{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-267676","form_type":"8-K","ticker":"AURA","cik":"0001501796","company_name":"Aura Biosciences, Inc.","filed_at":"2026-06-11T20:31:01+00:00","discovered_at":"2026-06-11T20:32:00.248725+00:00","generated_at":"2026-06-11T20:39:51.440114+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Aura Biosciences stockholders elect directors, ratify auditor at 2026 annual meeting","bullets":["David Johnson elected Class II director with 34,542,193 votes for, 6,628,297 withheld.","Teresa Marie Bitetti elected Class II director with 40,526,332 votes for, 644,158 withheld.","Ratification of Ernst & Young as auditor passed with 52,752,601 for, 17,348 against, 14,795 abstentions.","Total shares present or represented: 52,784,744 out of 64,199,778 eligible."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-267676","json":"https://secwatch.observer/filing/0001193125-26-267676.json","markdown":"https://secwatch.observer/filing/0001193125-26-267676.md","text":"https://secwatch.observer/filing/0001193125-26-267676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/0001193125-26-267676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/aura-20260611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T20:39:51.440114+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"584517744127221f31aafd3b608020e746ee6e8d","claim":"Aura Biosciences, Inc. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2026-06-11 meeting.","evidence_excerpt":"Proposal 2 - Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Votes For Votes Against Abstentions 52,752,601 17,348 14,795 There were zero broker non-votes regarding this proposal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/0001193125-26-267676-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"},{"claim_id":"d41d5587f5588541b8af9f77431cb0b16a8a7433","claim":"Aura Biosciences, Inc. shareholders approved Election of Class II Directors at the 2026-06-11 meeting.","evidence_excerpt":"Proposal 1 - Election of Directors The Company’s stockholders elected the two (2) director nominees below to the Company’s Board of Directors as Class II directors to serve until the 2029 Annual Meeting of Stockholders of the Company and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Director Nominee Votes For Votes Withheld Broker Non-Votes David Johnson 34,542,193 6,628,297 11,614,254 Teresa Marie Bitetti 40,526,332 644,158 11,614,254","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/0001193125-26-267676-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-11"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}